RAFAEL HOLDINGS, INC. Convertible Notes Payable, Noncurrent
RAFAEL HOLDINGS, INC. (RFL) had Convertible Notes Payable, Noncurrent of $2.00 thousand as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2026-06-11
- 2026-04-30: Convertible Notes Payable, Noncurrent $2.00K.
- 2026-01-31: Convertible Notes Payable, Noncurrent $52.00K.
- 2025-10-31: Convertible Notes Payable, Noncurrent $56.00K.
- 2025-07-31: Convertible Notes Payable, Noncurrent $78.00K.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2026-04-30 | $2.00K 10-Q · filed 2026-06-11 |
| 2026-01-31 | $52.00K 10-Q · filed 2026-03-16 |
| 2025-10-31 | $56.00K 10-Q · filed 2025-12-12 |
| 2025-07-31 | $78.00K 10-Q · filed 2026-06-11 |
| 2025-04-30 | $76.00K 10-Q · filed 2025-06-11 |
| 2025-01-31 | $75.00K 10-Q · filed 2025-03-14 |
| 2024-10-31 | $74.00K 10-Q · filed 2024-12-11 |
| 2024-07-31 | $73.00K 10-K · filed 2025-10-29 |
| 2024-04-30 | $71.00K 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |